Editorial: Neuropsychiatric and neurodegenerative aspects of acute and long COVID

Editorial: Neuropsychiatric and neurodegenerative aspects of acute and long COVID

Bibliographic Details
Main Authors:	Abbas F. Almulla, Hussein K. Al-Hakeim
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-12-01
Series:	Frontiers in Molecular Neuroscience
Subjects:	COVID-19 neuropsychiatric disorders neurodegenerative diseases neuroinflammation long COVID chronic fatigue syndrome
Online Access:	https://www.frontiersin.org/articles/10.3389/fnmol.2023.1343930/full

Similar Items

Chronic Fatigue, Depression and Anxiety Symptoms in Long COVID Are Strongly Predicted by Neuroimmune and Neuro-Oxidative Pathways Which Are Caused by the Inflammation during Acute Infection
by: Hussein Kadhem Al-Hakeim, et al.
Published: (2023-01-01)

Multiple Aspects of Inappropriate Action of Renin–Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases
by: Ewa Szczepanska-Sadowska, et al.
Published: (2022-02-01)

Mood Symptoms and Chronic Fatigue Syndrome Due to Relapsing-Remitting Multiple Sclerosis Are Associated with Immune Activation and Aberrations in the Erythron
by: Abbas F. Almulla, et al.
Published: (2023-07-01)

Exosomes as Emerging Biomarker Tools in Neurodegenerative and Neuropsychiatric Disorders—A Proteomics Perspective
by: Boby Mathew, et al.
Published: (2021-02-01)

Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders
by: Katelyn Cuttler, et al.
Published: (2021-10-01)

Advances in the role of the GADD45 family in neurodevelopmental, neurodegenerative, and neuropsychiatric disorders
by: Mengbing Huang, et al.
Published: (2024-01-01)

Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVID
by: Hussein Kadhem Al-Hakeim, et al.
Published: (2023-06-01)

COVID-19 impacts the expression of molecular markers associated with neuropsychiatric disorders
by: André Quincozes-Santos, et al.
Published: (2021-02-01)

Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
by: Hiroki Ishiguro, et al.
Published: (2022-06-01)

Editorial: Unravelling the role of CB2r in neuropsychiatric diseases
by: Emmanuel S. Onaivi
Published: (2023-03-01)

The Role of Lysophosphatidic Acid in Neuropsychiatric and Neurodegenerative Disorders
by: Simona Dedoni, et al.
Published: (2024-03-01)

Pathway Phenotypes Underpinning Depression, Anxiety, and Chronic Fatigue Symptoms Due to Acute Rheumatoid Arthritis: A Precision Nomothetic Psychiatry Analysis
by: Hasan Najah Smesam, et al.
Published: (2022-03-01)

The Significance of NLRP Inflammasome in Neuropsychiatric Disorders
by: Yao Shen, et al.
Published: (2022-08-01)

The emerging role of furin in neurodegenerative and neuropsychiatric diseases
by: Yi Zhang, et al.
Published: (2022-08-01)

In major dysmood disorder, physiosomatic, chronic fatigue and fibromyalgia symptoms are driven by immune activation and increased immune-associated neurotoxicity
by: Michael Maes, et al.
Published: (2024-03-01)

Lowered serum cesium levels in schizophrenia: association with immune-inflammatory biomarkers and cognitive impairments
by: Abbas F. Almulla, et al.
Published: (2020-06-01)

Neuropsychiatric Disorders in Pediatric Long COVID-19: A Case Series
by: Rosa Savino, et al.
Published: (2022-04-01)

Editorial: Biology of Brain Disorders
by: Daniela Tropea, et al.
Published: (2017-11-01)

Increased insulin resistance is associated with depressive symptoms due to long COVID
by: Michael Maes, et al.
Published: (2023-07-01)

Utilizing hiPSC-derived oligodendrocytes to study myelin pathophysiology in neuropsychiatric and neurodegenerative disorders.
by: Gina Shim, et al.
Published: (2024-01-01)

Aspects of animal models for major neuropsychiatric disorders
by: Lefter Radu, et al.
Published: (2014-01-01)

White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases
by: Miracle Ozzoude, et al.
Published: (2023-06-01)

The role of the microbiota-gut-brain axis in neuropsychiatric disorders
by: Jaqueline S. Generoso, et al.
Published: (2020-07-01)

Co-Expression Network Analysis Identifies Molecular Determinants of Loneliness Associated with Neuropsychiatric and Neurodegenerative Diseases
by: Jose A. Santiago, et al.
Published: (2023-03-01)

Systems Bioinformatics Reveals Possible Relationship between COVID-19 and the Development of Neurological Diseases and Neuropsychiatric Disorders
by: Anna Onisiforou, et al.
Published: (2022-10-01)

Kynurenine 3-monooxygenase: an influential mediator of neuropathology
by: Jennifer M Parrott, et al.
Published: (2015-08-01)

Glycomic and Glycoproteomic Techniques in Neurodegenerative Disorders and Neurotrauma: Towards Personalized Markers
by: Firas Kobeissy, et al.
Published: (2022-02-01)

Neuropsychiatric Aspects of Huntington’s Disease
by: Özlem Devrim Balaban, et al.
Published: (2022-03-01)

COVID-19: Neuropsychiatric manifestations and psychopharmacology
by: Harpreet Singh Dhillon, et al.
Published: (2020-01-01)

The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis
by: Abbas F. Almulla, et al.
Published: (2022-07-01)

Increased insulin resistance due to long COVID is associated with depressive symptoms and partly predicted by the inflammatory response during acute infection
by: Hussein Kadhem Al-Hakeim, et al.
Published: (2023-05-01)

Influencia de la infección SARS-CoV-2 sobre enfermedades neurodegenerativas y neuropsiquiátricas: ¿una pandemia demorada?
by: P.J. Serrano-Castro, et al.
Published: (2020-05-01)

Recurrent Implication of Striatal Cholinergic Interneurons in a Range of Neurodevelopmental, Neurodegenerative, and Neuropsychiatric Disorders
by: Lauren A. Poppi, et al.
Published: (2021-04-01)

Prevalence and incidence of neuropsychiatric disorders in post hospitalized COVID-19 patients in South America: a systematic review and meta-analysis
by: Francisco Perea-Flórez, et al.
Published: (2023-11-01)

Research and Diagnostic Algorithmic Rules (RADAR) and RADAR Plots for the First Episode of Major Depressive Disorder: Effects of Childhood and Recent Adverse Experiences on Suicidal Behaviors, Neurocognition and Phenome Features
by: Michael Maes, et al.
Published: (2023-04-01)

Neuropsychiatric implications of covid-19 infection: A case report
by: P. Coucheiro Limeres, et al.
Published: (2022-06-01)

Neuropsychiatric phenotype of post COVID-19 syndrome in non-hospitalized patients
by: Julia Lier, et al.
Published: (2022-09-01)

Involvement of an Aberrant Vascular System in Neurodevelopmental, Neuropsychiatric, and Neuro-Degenerative Diseases
by: Keiichi Ishihara, et al.
Published: (2023-01-01)

NEUROPSYCHIATRIC CONSEQUENCES OF COVID-19
by: N. N. Petrova
Published: (2022-08-01)

Patients with unmet social needs are at higher risks of developing severe long COVID-19 symptoms and neuropsychiatric sequela
by: Anna Eligulashvili, et al.
Published: (2024-04-01)